http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2002365-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37975d741e8bc293ff5ffd67fe941f82 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 |
| filingDate | 1989-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47d4b408a637a2e6c7e64c65b19f2b6f |
| publicationDate | 1991-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2002365-A1 |
| titleOfInvention | Process of purifying a cytolytic toxin from plant garcinia morella desv. (g.m.d.) resin for anticancer study |
| abstract | Abstract An active component with high chemical stability was identified and purified from resin of plant G.M.D. The resulting product has been extensively studied for its pharmacological and toxicological activities. Data indicated that the active component functions as an very potent cytolytic chemical compound. Cells were irreversibly killed at very low concentration less than 10ng per ml.With such low concentration, there was however, very little evidence of intoxication. In this report, I have invented various rapid methods for extracting the active component GMD 1630 in large quantity and way of long term storage. Also, in vitro bioassays and in vivo tests for monitoring intoxication were designed. |
| priorityDate | 1989-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.